Should additional deeper sections (extra levels) be performed on a negative cervical biopsy when clinical suspicion for occult disease remains?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should Extra Levels Be Performed on Negative Cervical Biopsies?

Yes, additional deeper histologic sections should be obtained when there is clinical-pathologic discordance, such as positive high-risk HPV testing, abnormal cytology, or suspicious colposcopic findings despite an initially negative cervical biopsy.

Rationale and Evidence-Based Approach

The decision to perform extra levels hinges on whether clinical suspicion remains after the initial negative result. This is not a routine practice for all negative biopsies, but rather a targeted strategy for specific scenarios.

When to Order Additional Levels

Obtain 1-3 additional deeper sections in these situations:

  • HPV-cytology-histology discordance: When high-risk HPV testing is positive but initial biopsy is negative 1
  • Abnormal cytology with negative biopsy: Particularly with ASC-US or higher-grade cytologic abnormalities 1
  • Missing squamocolumnar junction: When the transformation zone is not adequately sampled 2
  • Suspected invasive disease: Based on cytology, colposcopy, or clinical presentation 2
  • Colposcopic impression suggests disease: When visual findings are more severe than histologic results 1

Evidence Supporting This Approach

The research demonstrates significant diagnostic yield from additional levels. In patients with positive high-risk HPV and initially negative biopsies, examining three additional H&E levels revealed:

  • 31% had clinically significant lesions that were missed initially 1
  • CIN 2/3 was found in 8% of cases 1
  • HPV infection or CIN 1 in 19% 1

For cone biopsies and LLETZ specimens, examining one additional deeper level identified CIN for the first time in 5 cases and upgraded CIN 1 in 5 more cases, with invasive cancer discovered in 2 cases initially showing only high-grade CIN 2.

Practical Protocol

For standard cervical biopsies with discordance:

  • Request 1-2 additional levels initially 2
  • If invasive disease is suspected, request 2 additional levels 2

For cone/LLETZ specimens:

  • One additional level is generally sufficient when the squamocolumnar junction is missing or there's clinical discordance 2
  • Two additional levels when invasion is suspected 2

Important Caveats

The first superficial level in routine three-level protocols may not be representative and contributes minimally to diagnosis 3. The diagnostic value comes from examining deeper tissue sections when initial results don't explain the clinical picture, not from routine multiple levels on all specimens.

Close clinical follow-up remains essential even with additional levels, as 25% of patients with initially negative biopsies and positive HPV showed squamous abnormalities on subsequent follow-up 1. This reflects both sampling limitations and the temporal nature of cervical disease progression.

Quality Assurance Consideration

Interobserver variation in histologic interpretation is a significant factor in diagnostic discordance 3. When requesting additional levels, consider having a second pathologist review the case, as this may be more valuable than simply cutting more tissue in some instances.

The key principle: Additional levels are a targeted diagnostic tool for resolving clinical-pathologic discordance, not a routine screening measure for all negative cervical biopsies.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.